
Sign up to save your podcasts
Or
In this episode, Vic and Marcus cover a wide range of developments shaping the healthcare, economic, and tech landscapes. They begin with inflation concerns, interest rate policies, and Powell’s positioning, then dive into Starbucks' return-to-office mandate as a signal for white-collar layoffs and broader workforce trends. The conversation shifts to AI’s impact on productivity, rare earth material independence in the U.S., and startup funding in nurse scheduling and medical AI tools. They dissect the CMS’s proposed rule eliminating the inpatient-only list and its ripple effects across SaaS reimbursement, telehealth, and digital therapeutics. The pair also examine policy shifts affecting Medicare, Medicaid, and cell and gene therapy pilots. Payer market turmoil, hospital M&A dynamics, and pharma’s contrasting success round out the business update. They close with reflections on U.S.-China AI competition, regulatory loopholes in talent acquisitions, and how stablecoin and voice AI advances could transform healthcare.
Links:
3:57 - Inflation Picks Up to 2.7% as Tariffs Start to Seep Into Prices WSJ
5:15 - Starbucks Tells White-Collar Workers to Come to the Office More—Or Take a Buyout WSJ
15:36 - America’s Biggest Rare-Earth Producer Makes a Play to End China’s Dominance WSJ
18:15 - M7 Health nabs $10M to modernize nurse staffing and scheduling Fierce Healthcare
20:17 - OpenEvidence raises $210M, unveils AI agents built for advanced medical research Fierce Healthcare
23:33 - Fellow Health: $24 Million Series B Raised For Expanding Male Reproductive Test Offerings Pulse 2.0
24:32 - CMS Eliminating the Inpatient Only (IPO) List CMS website
29:04 - Trump 2.0 backs digital health in proposed CY2026 physician fee schedule rule Fierce Healthcare
34:11 - CMS officially names participants in Cell and Gene Therapy Access Model Fierce Healthcare
36:18 - F.D.A. Panel to Reassess Hormone Therapy Warnings NYT
40:08 - Elevance Health lowers 2025 guidance amid cost pressures in ACA, Medicaid markets Fierce Healthcare
41:17 - Centene, Elevance, Molina squeezed as exchanges deteriorate Modern Healthcare
43:57 - Geisinger layoffs hit insurance division Modern Healthcare
44:43 - Nonprofits ChristianaCare, Virtua Health explore merger Health Care Dive
46:00 - M&A Quarterly Activity Report: Q2 2025 KaufmanHall
47:46 - Private-Equity Firms Bain and Kohlberg Make Another Big Bet on Biopharma Industry WSJ
48:35 - Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs. WSJ
50:03 - J&J Raises Full-Year Outlook After Beating Profit Expectations WSJ
53:17 - Upended by Meth, Some Communities Are Paying Users to Quit NYT
57:32 - Crypto rises on renewed optimism House will pass key stablecoin le
HF Site
YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK
4.5
4040 ratings
In this episode, Vic and Marcus cover a wide range of developments shaping the healthcare, economic, and tech landscapes. They begin with inflation concerns, interest rate policies, and Powell’s positioning, then dive into Starbucks' return-to-office mandate as a signal for white-collar layoffs and broader workforce trends. The conversation shifts to AI’s impact on productivity, rare earth material independence in the U.S., and startup funding in nurse scheduling and medical AI tools. They dissect the CMS’s proposed rule eliminating the inpatient-only list and its ripple effects across SaaS reimbursement, telehealth, and digital therapeutics. The pair also examine policy shifts affecting Medicare, Medicaid, and cell and gene therapy pilots. Payer market turmoil, hospital M&A dynamics, and pharma’s contrasting success round out the business update. They close with reflections on U.S.-China AI competition, regulatory loopholes in talent acquisitions, and how stablecoin and voice AI advances could transform healthcare.
Links:
3:57 - Inflation Picks Up to 2.7% as Tariffs Start to Seep Into Prices WSJ
5:15 - Starbucks Tells White-Collar Workers to Come to the Office More—Or Take a Buyout WSJ
15:36 - America’s Biggest Rare-Earth Producer Makes a Play to End China’s Dominance WSJ
18:15 - M7 Health nabs $10M to modernize nurse staffing and scheduling Fierce Healthcare
20:17 - OpenEvidence raises $210M, unveils AI agents built for advanced medical research Fierce Healthcare
23:33 - Fellow Health: $24 Million Series B Raised For Expanding Male Reproductive Test Offerings Pulse 2.0
24:32 - CMS Eliminating the Inpatient Only (IPO) List CMS website
29:04 - Trump 2.0 backs digital health in proposed CY2026 physician fee schedule rule Fierce Healthcare
34:11 - CMS officially names participants in Cell and Gene Therapy Access Model Fierce Healthcare
36:18 - F.D.A. Panel to Reassess Hormone Therapy Warnings NYT
40:08 - Elevance Health lowers 2025 guidance amid cost pressures in ACA, Medicaid markets Fierce Healthcare
41:17 - Centene, Elevance, Molina squeezed as exchanges deteriorate Modern Healthcare
43:57 - Geisinger layoffs hit insurance division Modern Healthcare
44:43 - Nonprofits ChristianaCare, Virtua Health explore merger Health Care Dive
46:00 - M&A Quarterly Activity Report: Q2 2025 KaufmanHall
47:46 - Private-Equity Firms Bain and Kohlberg Make Another Big Bet on Biopharma Industry WSJ
48:35 - Trump Says 200% Pharma Tariffs Are Coming. Wall Street Shrugs. WSJ
50:03 - J&J Raises Full-Year Outlook After Beating Profit Expectations WSJ
53:17 - Upended by Meth, Some Communities Are Paying Users to Quit NYT
57:32 - Crypto rises on renewed optimism House will pass key stablecoin le
HF Site
YOUTUBE
INSTAGRAM
TWITTER
FACEBOOK
LINKEDIN
TIKTOK
32,291 Listeners
1,040 Listeners
16,101 Listeners
519 Listeners
43,483 Listeners
30,224 Listeners
111,917 Listeners
56,231 Listeners
9,568 Listeners
7,953 Listeners
5,942 Listeners
391 Listeners
5,414 Listeners
9,236 Listeners
277 Listeners